About Us

Blue Ocean Oncology operates at the intersection of emerging cancer science and strategic decision-making. We support early-stage oncology innovators in clarifying differentiation, sharpening narrative, and guiding high-stakes decisions before commercialization. Our work is intentionally focused and selective, engaging teams at critical inflection points in development.

Blue Ocean Oncology was founded by Marina Oraczewski, PhD, whose experience spans oncology brand strategy, competitive positioning, and asset-level thinking across multiple tumor types.